17 minutes | May 23rd 2018

145 - Sotagliflozin for T1DM; DTRAX® Spinal System; denosumab for glucocorticoid-induced osteoporosis; avatrombopag for thrombocytopenia in CLD; stent retriever device for ischemic stroke; Restylane dermal filler for hands.

Wednesday, May 23, 2018 Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 0:45 FDA to review Zynquista™ (sotagliflozin) as potential treatment for type 1 diabetes https://www.prnewswire.com/news-releases/fda-to-review-zynquista-sotagliflozin-as-potential-treatment-for-type-1-diabetes-300652146.html 2:10 Providence Medical Technology announces FDA 510(k) clearance for DTRAX® Spinal System https://www.prnewswire.com/news-releases/providence-medical-technology-announces-fda-510k-clearance-for-dtrax-spinal-system-300652309.html  3:38 FDA approves Prolia® (denosumab) for glucocorticoid-induced osteoporosis https://www.prnewswire.com/news-releases/fda-approves-prolia-denosumab-for-glucocorticoid-induced-osteoporosis-300652126.html  5:20 FDA approves Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease https://www.prnewswire.com/news-releases/fda-approves-new-drug-for-patients-with-chronic-liver-disease-who-have-low-blood-platelets-and-are-undergoing-a-medical-procedure-300651897.html https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608320.htm 7:20 Cerenovus receives FDA clearance for next generation stent retriever device used to treat ischemic stroke https://www.prnewswire.com/news-releases/cerenovus-receives-fda-clearance-for-next-generation-stent-retriever-device-used-to-treat-ischemic-stroke-300651419.html  9:44 FDA approves Restylane® Lyft dermal filler for hands https://www.prnewswire.com/news-releases/nestle-skin-health-announces-the-fda-approval-of-restylane-lyft-for-hands-the-first-and-only-hyaluronic-acid-ha-dermal-filler-for-use-in-the-back-of-hands-300651736.html  11:04 New FDA actions to keep consumers safe from the harmful effects of sun exposure, and ensure the long-term safety and benefits of sunscreens https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608499.htm  Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.  Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Play
Like
Play Next
Mark
Played
Share